Nutrition Essentials in Cystic Fibrosis: CFF Guidelines, New Findings, &amp; Goals

Infectious Disease & Primary Care: A Conversation with IDWeek 2023 Chair

Adults receiving semaglutide for the first time achieved weight loss of 14.3% at 12 months vs 10.6% among those who had previously taken a different antiobesity drug.

October 25th 2023

FDA Approves First New Antibiotic in Decades for Uncomplicated UTI

Listen to our latest podcast episode with Heather Yun, MD, for details on emerging pathogens, the role of primary care clinicians in the effort to rein in antimicrobial resistance, and more.

Navigating Cardiovascular Complications of Obesity: Expert Insights for Primary Care

Pivmecillinam is an aminopenicillin, a class of beta-lactam antibiotics with a mechanism of action that may help reduce rising levels of antibiotic resistance.

August 30th 2023

Poor Cardiovascular Health at Midlife Linked to Cognitive Decline in Black Women

Listen to our latest podcast episode for details on top CVD risk factors to screen patients with obesity for, medications to help prevent CVD, and more.

Elevated Lp(a) Level Raises ASCVD Risk Regardless of Age, Sex, Race/Ethnicity: Daily Dose

Poor cardiovascular health at midlife was associated with a decline in the mental processing speed of Black women, but not White women, according to a new study.

Adults with Obesity Who Receive Semaglutide as First Weight Loss Medication Lose More Weight

Your daily dose of the clinical news you may have missed.

Related Content

Infectious Disease & Primary Care: A Conversation with IDWeek 2023 Chair

Adults receiving semaglutide for the first time achieved weight loss of 14.3% at 12 months vs 10.6% among those who had previously taken a different antiobesity drug.

October 25th 2023

FDA Approves First New Antibiotic in Decades for Uncomplicated UTI

Listen to our latest podcast episode with Heather Yun, MD, for details on emerging pathogens, the role of primary care clinicians in the effort to rein in antimicrobial resistance, and more.

Navigating Cardiovascular Complications of Obesity: Expert Insights for Primary Care

Pivmecillinam is an aminopenicillin, a class of beta-lactam antibiotics with a mechanism of action that may help reduce rising levels of antibiotic resistance.

August 30th 2023

Poor Cardiovascular Health at Midlife Linked to Cognitive Decline in Black Women

Listen to our latest podcast episode for details on top CVD risk factors to screen patients with obesity for, medications to help prevent CVD, and more.

Elevated Lp(a) Level Raises ASCVD Risk Regardless of Age, Sex, Race/Ethnicity: Daily Dose

Poor cardiovascular health at midlife was associated with a decline in the mental processing speed of Black women, but not White women, according to a new study.